1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Powers of Buyers
4.3.3. Threat of Substitutes
4.3.4. The threat of New Entrants
4.3.5. Competitive Rivalry in Industry
4.4. Industry Value Chain Analysis
5. USA DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION
5.1. Introduction
5.2. Topical
5.3. Injectable
5.4. Oral
5.5. Nasal
5.6. Others
6. USA DRUG DELIVERY MARKET, BY APPLICATION
6.1. Introduction
6.2. Treatment of diseases
6.3. Research/Academic purposes
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrative
7.3. Mergers, Acquisition, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. AstraZeneca
8.2. West Pharmaceutical Services, Inc.
8.3. Becton, Dickinson and Company
8.4. Medtronic
8.5. Merck & Co. Inc.
8.6. Antares Pharma
8.7. 3M (Kindeva Drug Delivery)
8.8. Aquestive therapeutics
8.9. Eli Lilly and Company
8.10. Enable Injections
8.11. CURE Pharmaceutical
8.12. Catalent, Inc.